The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

MPyVgp1  -  large T antigen

Murine polyomavirus

This record was discontinued.
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of MPyVgp1

 

High impact information on MPyVgp1

  • When added to a permeabilized cell system for nuclear import, the purified proteins increase by 2- to 3-fold the nuclear accumulation of a fluorescent protein containing the large T antigen NLS [5].
  • A mutant SV40 genome carrying a frameshift at the carboxyl terminus of the large T antigen failed to replicate SV40 DNA and to transform rat2 cells, although the altered region is known to be dispensable for these functions [6].
  • Analysis of plaques, obtained after transfection with SV40 DNA molecules harboring a single mispair in a defined orientation within the intron of the large T antigen gene, revealed that all types of base/base mispairs were corrected, albeit with different efficiencies and specificities [7].
  • In order to investigate viral oncogenesis, we generated transgenic mice carrying either the Py large T antigen (LT) gene or the Py middle T antigen (MT) gene linked to Py early region regulatory sequences [8].
  • Cells transformed by Polyoma virus (Py) can undergo a high rate of excision or amplification of integrated viral DNA sequences, and these phenomena require the presence of homology (i.e., repeats) within the viral insertion as well as a functional viral large T antigen (T-Ag) [9].
 

Chemical compound and disease context of MPyVgp1

 

Biological context of MPyVgp1

 

Anatomical context of MPyVgp1

  • To define the minimal cis-acting sequences required for polyomavirus DNA replication (ori), we constructed a number of polyomavirus-plasmid recombinants and measured their replicative capacity after transfection of a permissive mouse cell line capable of providing polyomavirus large T antigen in trans (MOP cells) [16].
  • By these techniques, the viral large T-antigen was found almost exclusively in the nucleus, sometimes in association with nuclear pores, but never in the nucleolus [19].
  • Thus, the results suggest that, for established Fischer rat fibroblasts, the maintenance of any of the three phenotypes tested and, in particular, of serum independence is not necessarily correlated with the levels of large T antigen or fragments thereof [20].
  • Synthetic peptides, 2 derived from the sequence common to small, middle and large T-antigen, and I derived from the sequence unique for middle T, activated lymphocytes from polyoma-virus-immunized, but not from control mice, to release the lymphokine migration inhibitory factor (MIF) [21].
  • The mutant nonkaryophilic large T antigen in NIH3T3 transformant was localized in cytoplasmic membrane fractions [22].
 

Associations of MPyVgp1 with chemical compounds

  • In addition, the 63,000- and 20,000-dalton antigens contained two other methionine peptides absent from the large T-antigen species [23].
  • These proteins had approximate molecular weights of 105,000 (large T antigen), 63,000 (middle T antigen), and 20,000 (small T antigen) as estimated by acrylamide gel electrophoresis [23].
  • Two mutants, ts-25 and ts-52, have different single-base changes at the same position (2883) in the early region corresponding to a conserved glycine residue very near the C-terminus of the polyoma large T antigen [24].
  • However, the prolongation of S and G2 phases in the presence of cycloheximide was not suppressed in cells expressing large T antigen, by infection with SV40 in the current generation [25].
  • Whereas small T-antigen and nuclear large T-antigen were fully immunoreactive, cytoplasmic large T-antigen reacted poorly with PAb 402 or polyclonal antibodies unless the mRNP moiety was removed by treatment with EDTA/RNase A [26].
 

Other interactions of MPyVgp1

 

Analytical, diagnostic and therapeutic context of MPyVgp1

  • To map the polyomavirus large T antigen binding sites on the viral genome we employed a quantitative immunoassay [3].
  • Peptide mapping studies of the SV3T3 C120 super T-antigen were consistent with its being derived from an internally duplicated template, since the protein has methionine and cysteine tryptic fingerprints virtually identical to those of normal large T-antigen, with certain methionine peptides present in greater than one molar yield [27].
  • Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role [28]?
  • As shown by immunoblotting, 125I-labeled PAb 416 was bound to a 17-kDa N-terminal fragment of large T-antigen (amino acid residues 1-130), and PAb 423 was bound to several overlapping fragments derived from the C terminus of large T-antigen [26].
  • Microinjection of either mutant C6 SV40 DNA, which encodes a large T antigen unable to bind specifically to viral regulatory sequences, or deleted viral DNA lacking part of the large T antigen coding sequences yielded ratios of L-strand to E-strand RNA that were similar to those observed with wild-type SV40 DNA [29].

References

  1. Genomic structure of human polyoma virus JC: nucleotide sequence of the region containing replication origin and small-T-antigen gene. Miyamura, T., Jikuya, H., Soeda, E., Yoshiike, K. J. Virol. (1983) [Pubmed]
  2. Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens. Soeda, E., Arrand, J.R., Smolar, N., Griffin, B.E. Cell (1979) [Pubmed]
  3. Polyomavirus large T antigen binds independently to multiple, unique regions on the viral genome. Pomerantz, B.J., Mueller, C.R., Hassell, J.A. J. Virol. (1983) [Pubmed]
  4. Construction of a helper-free recombinant adenovirus that expresses polyomavirus large T antigen. Massie, B., Gluzman, Y., Hassell, J.A. Mol. Cell. Biol. (1986) [Pubmed]
  5. Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Adam, S.A., Gerace, L. Cell (1991) [Pubmed]
  6. A mutant SV40 large T antigen interferes with nuclear localization of a heterologous protein. Schneider, J., Schindewolf, C., van Zee, K., Fanning, E. Cell (1988) [Pubmed]
  7. Different base/base mispairs are corrected with different efficiencies and specificities in monkey kidney cells. Brown, T.C., Jiricny, J. Cell (1988) [Pubmed]
  8. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Bautch, V.L., Toda, S., Hassell, J.A., Hanahan, D. Cell (1987) [Pubmed]
  9. Amplification and excision of integrated polyoma DNA sequences require a functional origin of replication. Pellegrini, S., Dailey, L., Basilico, C. Cell (1984) [Pubmed]
  10. Different forms of simian virus 40 large tumor antigen varying in their affinities for DNA. Gidoni, D., Scheller, A., Barnet, B., Hantzopoulos, P., Oren, M., Prives, C. J. Virol. (1982) [Pubmed]
  11. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1. Murphy, D., Bishop, A., Rindi, G., Murphy, M.N., Stamp, G.W., Hanson, J., Polak, J.M., Hogan, B. Am. J. Pathol. (1987) [Pubmed]
  12. Localization of the phosphorylations of polyomavirus large T antigen. Bockus, B.J., Schaffhausen, B. J. Virol. (1987) [Pubmed]
  13. Characterization of the amino-terminal tryptic peptide of simian virus 40 small-t and large-T antigens. Mellor, A., Smith, A.E. J. Virol. (1978) [Pubmed]
  14. Guanine nucleotide contacts within viral DNA sequences bound by polyomavirus large T antigen. Cowie, A., Kamen, R. J. Virol. (1986) [Pubmed]
  15. A viable mouse polyomavirus mutant without immortalizing or transforming activities. Linder, S., Nilsson, M., Martens, I., Magnusson, G. Virology (1990) [Pubmed]
  16. Polyomavirus origin for DNA replication comprises multiple genetic elements. Muller, W.J., Mueller, C.R., Mes, A.M., Hassell, J.A. J. Virol. (1983) [Pubmed]
  17. Multiple binding sites for polyomavirus large T antigen within regulatory sequences of polyomavirus DNA. Cowie, A., Kamen, R. J. Virol. (1984) [Pubmed]
  18. Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome. Bendig, M.M., Thomas, T., Folk, W.R. J. Virol. (1980) [Pubmed]
  19. Subcellular localisation of the middle and large T-antigens of polyoma virus. Dilworth, S.M., Hansson, H.A., Darnfors, C., Bjursell, G., Streuli, C.H., Griffin, B.E. EMBO J. (1986) [Pubmed]
  20. Properties of cells transformed by the middle T-antigen-coding region of polyomavirus. Priehs, C., Friderici, K., Winberry, L., Fluck, M.M. J. Virol. (1986) [Pubmed]
  21. Polyoma T-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition. Reinholdsson, G., Ramqvist, T., Szigeti, R., Dalianis, T. Int. J. Cancer (1989) [Pubmed]
  22. Characterization of the chimeric SV40 large T antigen which has a membrane attachment sequence of polyoma virus middle T antigen. Segawa, K., Yamaguchi, N. Virology (1986) [Pubmed]
  23. Multiple forms of polyoma virus tumor antigens from infected and transformed cells. Simmons, D.T., Chang, C., Martin, M.A. J. Virol. (1979) [Pubmed]
  24. Nucleotide sequence changes in polyoma ts-a mutants: correlation with protein structure. Deininger, P.L., LaPorte, P., Friedmann, T. J. Virol. (1981) [Pubmed]
  25. Non-specific elongation of cell cycle phases by cycloheximide in rat 3Y1 cells, and specific reduction of G1 phase elongation by simian virus 40 large T antigen. Okuda, A., Kimura, G. J. Cell. Sci. (1988) [Pubmed]
  26. Binding sites for monoclonal antibodies and for mRNPs on SV40 large T-antigen determined with a cleavage map. Schwyzer, M., Tai, Y., Studer, E., Michel, M.R. Eur. J. Biochem. (1983) [Pubmed]
  27. Structure and synthesis of a simian virus 40 super T-antigen. Lovett, M., Clayton, C.E., Murphy, D., Rigby, P.W., Smith, A.E., Chaudry, F. J. Virol. (1982) [Pubmed]
  28. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role? Dalianis, T., Ramqvist, T., Klein, G. Int. J. Cancer (1984) [Pubmed]
  29. Regulation of simian virus 40 gene expression in Xenopus laevis oocytes. Michaeli, T., Prives, C. Mol. Cell. Biol. (1985) [Pubmed]
 
WikiGenes - Universities